Lyzor Tx – AI platform for the faster selection of bacteriophages against resistant bacterial infections
Biotech Healthtech AI in healthcare Generation: 2026. Founders: Lorena Derežanin, Zvonimir-Zoltan Marić, Sandra Kolundžija, Mateja Sigur Business model: B2B, B2B2C, SaaS/PaaS Lyzor Therapeutics is developing an AI platform for predicting interactions between bacteriophages and bacteria. The goal is to accelerate and reduce the scope of laboratory testing of bacteriophages needed to identify therapeutic candidates for…



